CCR2 and B-cell chronic lymphocytic leukemia: We show that low intracellular ROS in CLL cells lead to enhanced activation of the p65 subunit of NF-κB and increased expression of the chemokine receptors CCR2, CXCR3 and CCR7, a defect that was reversed by restoring p66Shc expression.